Redburn Atlantic upgraded shares of Lonza Group (OTCMKTS:LZAGY – Free Report) to a strong-buy rating in a report issued on Wednesday morning,Zacks.com reports.
Separately, The Goldman Sachs Group upgraded Lonza Group to a “strong-buy” rating in a report on Wednesday, October 9th.
Check Out Our Latest Research Report on LZAGY
Lonza Group Stock Performance
Lonza Group Company Profile
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Stories
- Five stocks we like better than Lonza Group
- What is the S&P/TSX Index?
- ServiceNow: Will the High-Flyer Finally Split in 2024?
- Compound Interest and Why It Matters When Investing
- MarketBeat Week in Review – 11/25 – 11/29
- What Are Growth Stocks and Investing in Them
- These 3 Stocks Are Heavy Hitters in Alternative Asset Management
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.